PPD
NASDAQPPD, Inc.
Latest news
25 items- NEWSInnoCare Pharma Goes Back to Funding Trough With STAR Market ListingKey Takeaways: InnoCare Pharma’s A-share IPO will make it the fourth innovative pharma company with shares traded in Hong Kong and on the mainland’s STAR Market The company is flush with cash and continues to raise money at every opportunity to finance its R&D By Molly Wen China’s Nasdaq-style STAR Market has become fertile ground for fundraising by innovative yet profit-challenged pharmaceutical companies since its launch in 2019. Some 33 biomedical companies went public there last year alone, accounting for 20% of all new listings in 2021. That honey pot has attracted yet another taker from the pharma space, with InnoCare Pharma Ltd. (9969.HK) announcing it received the regulat
- PRSaama Appoints Scott Rogers as Company's Chief Financial OfficerScott brings a unique combination of financial and clinical fused with growth experience to Saama New CFO appointment follows October announcement of $430M growth investment Saama Technologies, Inc. ("Saama") today announced that Scott Rogers, 17-year industry veteran, has been appointed as the company's Chief Financial Officer, effective January 31, 2022. In this position Scott is responsible for leading the company's global finance organization and will report to Saama Founder and CEO Suresh Katta. Scott comes to Saama with significant financial executive experience in clinical development, commercial growth, and financial reporting and compliance. He progressed rapidly through the
- SECSEC Form 15-12B filed by PPD, Inc.15-12B - PPD, Inc. (0001793294) (Filer)
- INSIDERSEC Form 4: Carlyle Group Inc. disposed of $2,646,829,818 worth of shares (55,722,733 units at $47.50)4 - PPD, Inc. (0001793294) (Issuer)
- 13D/GSEC Form SC 13G filed by PPD, Inc.SC 13G - PPD, Inc. (0001793294) (Subject)
- INSIDERSEC Form 4: H&F Corporate Investors Viii, Ltd. sold $6,309,960,135 worth of shares (132,841,266 units at $47.50)4 - PPD, Inc. (0001793294) (Issuer)
- INSIDERSEC Form 4: H&F Corporate Investors Vii, Ltd. sold $6,309,960,135 worth of shares (132,841,266 units at $47.50)4 - PPD, Inc. (0001793294) (Issuer)
- INSIDERSEC Form 4: Johnston David Michael returned $1,681,832 worth of shares to the company (60,929 units at $27.60) and was granted 25,522 shares, closing all direct ownership in the company4 - PPD, Inc. (0001793294) (Issuer)
- INSIDERSEC Form 4: Hill Colin returned $775,675 worth of shares to the company (16,330 units at $47.50), closing all direct ownership in the company4 - PPD, Inc. (0001793294) (Issuer)
- INSIDERSEC Form 4: Kaucic Karen returned $398,620 worth of shares to the company (31,496 units at $12.66) and was granted 23,104 shares, closing all direct ownership in the company4 - PPD, Inc. (0001793294) (Issuer)
- INSIDERSEC Form 4: Donovan Glen was granted 8,182 shares and returned $142,500 worth of shares to the company (11,182 units at $12.74), closing all direct ownership in the company4 - PPD, Inc. (0001793294) (Issuer)
- INSIDERSEC Form 4: James Julia returned $1,019,825 worth of shares to the company (42,334 units at $24.09) and was granted 20,864 shares, closing all direct ownership in the company4 - PPD, Inc. (0001793294) (Issuer)
- INSIDERSEC Form 4: Kindler Jeffrey B returned $5,604,382 worth of shares to the company (117,987 units at $47.50), closing all direct ownership in the company4 - PPD, Inc. (0001793294) (Issuer)
- INSIDERSEC Form 4: Fikry Christopher returned $598,642 worth of shares to the company (35,439 units at $16.89) and was granted 22,836 shares, closing all direct ownership in the company4 - PPD, Inc. (0001793294) (Issuer)
- INSIDERSEC Form 4: Scully Christopher G. returned $1,235,000 worth of shares to the company (61,262 units at $20.16) and was granted 35,262 shares, closing all direct ownership in the company4 - PPD, Inc. (0001793294) (Issuer)
- INSIDERSEC Form 4: Garrow Ronald E returned 21,492 shares to the company and was granted 21,492 shares4 - PPD, Inc. (0001793294) (Issuer)
- INSIDERSEC Form 4: Hilado Maria Teresa returned $1,869,742 worth of shares to the company (39,363 units at $47.50), closing all direct ownership in the company4 - PPD, Inc. (0001793294) (Issuer)
- INSIDERSEC Form 4: Thakral Anshul returned $1,625,735 worth of shares to the company (59,748 units at $27.21) and was granted 25,522 shares, closing all direct ownership in the company4 - PPD, Inc. (0001793294) (Issuer)
- INSIDERSEC Form 4: Sharbaugh William J returned $21,493,038 worth of shares to the company (494,909 units at $43.43) and was granted 42,424 shares, closing all direct ownership in the company4 - PPD, Inc. (0001793294) (Issuer)
- INSIDERSEC Form 4: Simmons David S returned $55,136,052 worth of shares to the company (1,461,671 units at $37.72) and was granted 300,912 shares, closing all direct ownership in the company4 - PPD, Inc. (0001793294) (Issuer)
- INSIDERSEC Form 4: Hartman Judd was granted 24,542 shares and returned $3,047,885 worth of shares to the company (88,708 units at $34.36), closing all direct ownership in the company4 - PPD, Inc. (0001793294) (Issuer)
- SECSEC Form S-8 POS filed by PPD, Inc.S-8 POS - PPD, Inc. (0001793294) (Filer)
- SECPPD, Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement, Other Events, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits8-K - PPD, Inc. (0001793294) (Filer)
- PRThermo Fisher Scientific Completes Acquisition of PPD, Inc.WALTHAM, Mass., Dec. 8, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced that it has completed its acquisition of PPD, Inc. (NASDAQ:PPD), a leading global provider of clinical research services to the biopharma and biotech industry, for $17.4 billion. "We are very excited to officially welcome our PPD colleagues to Thermo Fisher Scientific," said Marc N. Casper, chairman, president and chief executive officer of Thermo Fisher Scientific. "Expanding our value proposition for our biotech and pharmaceutical customers with the addition of PPD's leading clinical research services advances our work in bringing life-changing therapi
- SECSEC Form 25-NSE filed by PPD, Inc.25-NSE - PPD, Inc. (0001793294) (Subject)
PPD FAQ
7 questionsWhat does PPD, Inc. do?
PPD, Inc., together with its subsidiaries, provides drug development services to the biopharmaceutical industry worldwide. The company operates through two segments, Clinical Development Services and Laboratory Services. It offers clinical development services, including product development and consulting, early development, Phases II-IV clinical trial management, accelerated enrollment, peri-and post-approval, and medical communications services. The company also provides laboratory services comprising bioanalytical, biomarker, vaccine science, good manufacturing practice, and central...Where does PPD stock trade?
PPD, Inc. (PPD) is listed on NASDAQ.What sector and industry is PPD in?
PPD, Inc. operates in the Health Care sector, Biotechnology: Commercial Physical & Biological Resarch industry.When did PPD, Inc. go public?
PPD, Inc. (PPD) completed its IPO in 2020.What are analysts saying about PPD?
PPD, Inc. has had 1 recent analyst action on file. The most recent action was from Credit Suisse: Neutral with a $4750.00 price target on 2021-08-05. Recent price targets cluster around $4750.00.What companies are similar to PPD?
Notable peers in the same industry include IQV (IQVIA Holdings Inc.), INCY (Incyte Corp.), MEDP (Medpace Holdings Inc.), ICLR (ICON plc), SYNH (Syneos Health Inc.). Compare PPD side-by-side with any of them on Quantisnow.How can I track PPD on Quantisnow?
Quantisnow aggregates PPD, Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow PPD to receive live email and push alerts on every new disclosure.